Ngm Biopharmaceuticals Inc

+0.74 (+4.80%)
4:05:22 PM EDT: $15.81 -0.33 (-2.05%)
Earnings Announcements

NGM Bio Provides Business Highlights And Reports Q2 Financial Results

Published: 08/04/2022 21:16 GMT
Ngm Biopharmaceuticals Inc (NGM) - Ngm Bio Provides Business Highlights and Reports Second Quarter 2022 Financial Results.
Cash, Cash Equivalents and Short-term Marketable Securities Were $297.8 Million As of June 30, 2022.
Reported a Net Loss of $46.5 Million for Quarter Ended June 30, 2022.
Qtrly Net Loss per Share, Basic and Diluted $0.59.
Q2 Earnings per Share View $-0.55, Revenue View $11.9 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $9.18 Million
Adjusted EPS is expected to be -$0.59

Next Quarter Revenue Guidance is expected to be $9.43 Million
Next Quarter EPS Guidance is expected to be -$0.59

More details on our Analysts Page.